Immunovia AB (publ) (STO:IMMNOV)

Immunovia AB Revenue

Immunovia AB had revenue of 424.00K SEK in the quarter ending March 31, 2026, with 205.04% growth. This brings the company's revenue in the last twelve months to 908.00K, down -6.97% year-over-year. In the year 2025, Immunovia AB had annual revenue of 685.00K, down -26.42%.

• Revenue (ttm): 908.00K
• Revenue Growth: -6.97%
• P/S Ratio: 151.13
• Revenue / Employee: 69.85K
• Employees: 13
• Market Cap: 137.22M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	685.00K	-246.00K	-26.42%
Dec 31, 2024	931.00K	-644.00K	-40.89%
Dec 31, 2023	1.58M	430.00K	37.55%
Dec 31, 2022	1.15M	301.00K	35.66%
Dec 31, 2021	844.00K	482.00K	133.15%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 2, 2026

Data Sources Report a data error